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a b s t r a c t
Previously, RNA helicase A (RHA) re-localization from the nucleus to the cytoplasm in foot-and-mouth disease
virus (FMDV) infected cells was shown to coincide with loss of RHA methylated arginine residues at its
C-terminus. The potential interaction between RHA and Jumonji C-domain (JmjC) protein 6 (JMJD6) arginine
demethylase in infected cells was investigated. Treatment with N-oxalylglycine (NOG) inhibitor of JmjC
demethylases prevented FMDV-induced RHA demethylation and re-localization, and also decreased viral
protein synthesis and virus titers. Physical interaction between JMJD6 and RHA was demonstrated via
reciprocal co-immunoprecipitation, where RHA preferentially bound JMJD6 monomers. Nuclear efﬂux of
demethylated RHA (DM-RHA) coincided with nuclear inﬂux of JMJD6, which was not observed using another
picornavirus. A modiﬁed biochemical assay demonstrated JMJD6 induced dose-dependent demethylation of
RHA and two RHA-derived isoforms, which could be inhibited by NOG. We propose a role for JMJD6 in RHA
demethylation stimulated by FMDV, that appears to facilitate virus replication.
Published by Elsevier Inc.
Introduction
Picornavirus infection is known to induce changes in cell mem-
brane permeability and the nuclear membrane trafﬁcking by multiple
mechanisms. Crucial functions of these viruses also require the
redistribution of speciﬁc nuclear proteins into the host cell cytoplasm
where viral replication occurs (Gustin and Sarnow, 2002; Lawrence
and Rieder, 2009; Lawrence et al., 2012; McBride et al., 1996). The
nuclear efﬂux of host proteins is not a generalized redistribution,
rather only a certain subset of proteins is speciﬁcally re-localized by
mechanisms ranging from direct post-translational modiﬁcation
(PTM) of the protein to proteolytic cleavage by a viral encoded
protease (Back et al., 2002; Cammas et al., 2007; Lawrence and
Rieder, 2009; Lawrence et al., 2012; Shiroki et al., 1999) and nuclear
pore permeability alterations. RNA-binding proteins such as:
La autoantigen, nucleolin, poly-C binding protein (PCBP2), RNA heli-
case A (RHA), and the 68 kDa Src-associated substrate during mitosis
(Sam68) (Gustin and Sarnow, 2002; Lawrence and Rieder, 2009;
Lawrence et al., 2012; McBride et al., 1996; Niepmann et al., 1997)
are known to participate in the life cycles of several picornaviruses,
and are similarly re-localized during the course of virus infection.
Early studies have shown that the nuclear retention of RHA in
uninfected cells is based on the asymmetric di-methylation of
multiple arginine-glycine (RG) and arginine-glycine-glycine (RGG)
repeats found at the RHA C-terminus (Smith et al., 2004). More
recently, we showed that FMDV-induced RHA re-localization to the
cytoplasm is coincident with an increase in the level of non-
methylated RHA (DM-RHA) (Lawrence and Rieder, 2009). This
phenomenon was documented in part, based on the use of a
monoclonal antibody (anti-DM-RHA, ab53668, Abcam, Cambridge,
MA) directed against the RG/RGG box that appeared to only react
when RHA arginine residues were demethylated. Positive reaction
with the anti-DM-RHA antibody was also observed in uninfected
cells following treatment with a methylation inhibitor cocktail (MDA)
(Lawrence and Rieder, 2009). In a dose-dependent manner, pre-
treatment of cells with the MDA inhibitor resulted in increased FMDV
titers, suggesting that availability of DM-RHA was advantageous to
the progression of infection (Lawrence and Rieder, 2009). These
preliminary observations presented two possibilities: that FMDV
infection prevented arginine methylation of newly synthesized RHA
or that the virus was capable of inducing the “demethylation” of
existing RHA. We favored the latter hypothesis, as it is more
consistent with the timing of the DM-RHA re-localization, though
it is considerably more controversial.
Until recently, protein methylation was considered a static non-
reversible PTM, but recent reports have revealed that protein
methylation is dynamic and reversible (Chang et al., 2007;
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Hong et al., 2007; Ng et al., 2009; Shi et al., 2004; Swigut and
Wysocka, 2007; Tsukada et al., 2006; Xiang et al., 2007). To date,
several lysine demethylases have been described (Hong et al.,
2007; Huang et al., 2007; Ng et al., 2009; Nicholson and Chen,
2009; Shi et al., 2004; Swigut and Wysocka, 2007; Tsukada et al.,
2006; Xiang et al., 2007; Yamane et al., 2006), yet only one true
arginine demethylase has been identiﬁed: Jumonji C-domain
(JmjC) containing protein 6 (JMJD6) (Chang et al., 2007). Thus,
we hypothesized that JMJD6 might be responsible for the
demethylation of RHA during the course of infection with FMDV.
JMJD6 is described as both a lysyl hydroxylase and a histone
arginine demethylase, whereby arginine residues are demethylated
in a two-step chemical reaction and requires the presence of Fe (II)
and 2-oxoglutarate (2-OG) (Chang et al., 2007; Schneider and
Shilatifard, 2006; Trewick et al., 2005; Webby et al., 2009). First,
upon JMJD6 binding its substrate in the presence of 2-OG and Fe (II),
the methylated arginine residue undergoes oxidative decarboxyla-
tion, which results in a hydroxylated methyl ammonium group. This
intermediate is highly unstable, and is ultimately released as for-
maldehyde in the second step, resulting in a demethylated arginine
residue (Mantri et al., 2010; Mosammaparast and Shi, 2010).
In the current study, the relationship between the FMDV-induced
RHA demethylation and JMJD6 enzymatic activity was investigated.
First, we showed that at non-toxic doses an inhibitor of JmjC protein
demethylases (N-oxalylglycine, NOG) prevented cytoplasmic accumu-
lation of RHA during FMDV infection and resulted in lower virus titers.
Secondly, JMJD6 monomeric and multimeric forms were observed in
FMDV susceptible cell lines, and the progressive accumulation of
JMJD6 in the nucleus of FMDV-infected cells was demonstrated. The
nuclear accumulation of JMJD6 was simultaneous with the gradual
increase in co-precipitation of RHA and JMJD6 in FMDV-infected cells.
Finally, using a modiﬁed in vitro assay, arginine demethylation of RHA
was detected, which revealed that JMJD6 is involved in the demethy-
lation of RHA and 2 RHA-derived isoforms known as BAG53328.1 and
leukophysin (LKP). Importantly, the demethylation activity detected by
this modiﬁed assay could be inhibited by co-incubation with the JmjC
inhibitor, NOG.
Results
Multiple FMDV serotypes induce RHA demethylation and its
subsequent re-localization during infection in host cells.
In an earlier study, we reported that FMDV infection triggers
the redistribution of RHA from the nucleus to the cytoplasm, and
that this is due to the demethylation of arginine residues in the
C-terminal nuclear transport domain of RHA (DM-RHA), detect-
able using a monoclonal antibody that only recognized non-
methylated residues (Lawrence and Rieder, 2009). To determine
whether the accumulation of DM-RHA in the cytoplasm can be
seen in other relevant FMDV serotypes, we infected LFBK cells
with FMDV strains: A24 Cruzeiro, O1 Campos, and C3 Resende at a
multiplicity of infection (MOI) of 10, incubated at 37 1C for 1, 3, and
5 h post-infection (hpi), and examined them by IFM. The data in
Fig. 1A shows punctate cytoplasmic ﬂuorescence associated with
DM-RHA detectable by 3 hpi for all these viruses, which progres-
sively increased by 5 hpi, in agreement with our earlier report
(Lawrence and Rieder, 2009). Moreover, we were able to rule out a
direct involvement of the CRM-1 nuclear export pathway in the
DM-RHA efﬂux process, as the punctate ﬂuorescent pattern for
DM-RHA in the cytoplasm of infected cells was similar whether
leptomycin B (LMB) nuclear export inhibitor was present or not
(Supplementary Fig. 1). Fig. 1B displays the schematic representa-
tion of the C-terminal RG/RGG box of RHA and the target sequence
for the anti DM-RHA antibody.
Next, we validated our detection system using Western blot
analysis to determine how endogenous RHA from mammalian cell
lines and GST-tagged RHA proteins expressed in Escherichia coli are
differentially identiﬁed using a rabbit polyclonal antibody against
RHA and the mouse monoclonal anti-DM-RHA described above
(Aratani et al., 2001; Lawrence and Rieder, 2009). Fig. 1C shows
that in uninfected lysates from 3 different FMDV-susceptible cell
lines, total RHA was detectable using a RHA-speciﬁc polyclonal
antibody, but not when the anti-DM-RHA antibody was used.
Moreover, we show byWestern blot, that GST-tagged RHA4, which
contains the C-terminal RHA domain, expressed in bacteria exhib-
ited positive reaction with both anti-GST and anti-DM-RHA anti-
bodies (Fig. 1D). These results are consistent with the knowledge
that methyltransferase enzymes, such as, PRMT1, are conserved
throughout eukaryotes but not prokaryotes (Bachand, 2007;
Krause et al., 2007). These ﬁndings demonstrate the usefulness
of the anti-DM-RHA antibody as a tool to examine the fate of DM-
RHA during the course of FMDV infection.
An inhibitor of JmjC protein demethylases prevents RHA
demethylation and re-localization and results in reduced viral protein
expression and titers in FMDV-infected cells.
We evaluated N-oxalylglycine (NOG), an inhibitor of the JmjC
domain containing family of protein demethylases, which is
known to compete with 2-OG in a dose-dependent manner
(Hamada et al., 2009; Han et al., 2012; Suzuki and Miyata, 2011);
(Chang et al., 2007). To this end, cells grown in monolayers were
incubated for 24 h (h) at 37 1C with a range of concentrations of
NOG, and subsequently examined for evidence of activity and
cytotoxicity. As shown in Fig. 2A, no signiﬁcant cytotoxic effects
were observed at any of the tested doses of NOG. A dose of 2 mM
NOG was selected for subsequent experiments as it was previously
described to successfully impede the demethylation of protein
substrates by Jumonji domain containing demethylases (Hamada
et al., 2009). Next, we examined cells by IFM that were pre-treated
with either media alone or media supplemented with 2 mM NOG,
followed by challenge with A24 Cruzeiro at a MOI of 10. The
infection was allowed to proceed for 5 h in the presence or
absence of the NOG inhibitor. Treated cells were then ﬁxed and
stained with anti-RHA and DAPI (Fig. 2B). (B) shows that treated
cells at early time points of infection as well as untreated mock-
infected cells exhibited exclusively nuclear RHA. As expected,
when infection progressed in untreated cells, RHA showed a split
distribution between the nucleus and the cytoplasm in agreement
with previous ﬁndings. In contrast, in the infected cells pre-treated
with 2 mM NOG, the results demonstrated exclusively nuclear
RHA up to 5 hpi. The effect of NOG treatment in infected cells was
further analyzed using an infectivity assay with a range of non-
toxic NOG concentrations and infecting with FMDV at a MOI of
0.001 for 24 h (Fig. 2). The harvested samples were examined for
the presence of FMDV proteins (Fig. 2C) and virus titers (Fig. 2D).
Results demonstrated a signiﬁcant reduction in virus protein
expression by Western blot analysis by approximately 89%
(Fig. 2C). Correspondingly, a gradual reduction in virus titers was
detected with differences of approximately 2.7 logs (Fig. 2D)
observed at the highest NOG dose tested (6 mM). Based on the
decrease of viral protein expression observed by Western blot
(Fig. 2C), we would have expected an even greater reduction in
virus titer (Fig. 2D). However, we attribute the disparity to
differences in sensitivity between the assays as well as the afﬁnity
of the antibody employed. Together, the results provide evidence
that a JmjC protein demethylase was involved in the demethyla-
tion of RHA during FMDV infection in host cells. Since JMJD6 is
only member of the JmjC family of proteins known to exhibit
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arginine demethylase activity, we focused on JMJD6 in down-
stream experiments.
Assessment of JMJD6 expression in different mammalian cell lines.
An experiment was designed to investigate JMJD6 expression in
susceptible bovine and hamster cells (LFBK and BHK-21, respec-
tively) (Swaney, 1988) as well as in the Chinese hamster ovary
(CHO) 677 cell line (Esko et al., 1988), which lacks the integrins
used as receptors by FMDV but can be productively infected by
mutant FMD viruses (Lawrence et al., 2013) by means of an
unknown alternative receptor. Whole cell lysates (WCL) as well
as nuclear (N) and cytoplasmic (C) fractions were prepared from
uninfected cells, and examined by Western blot using polyclonal
anti-RHA and anti-JMJD6 antibodies. One representative Western
blot out of ﬁve is shown for RHA (Fig. 3A) and JMJD6 (Fig. 3B). In
Fig. 3B, we detected multiple bands that reacted with the
C-terminal JMJD6 antibody (shown), which was recapitulated
using a N-terminal JMJD6 antibody, 2 additional rabbit polyclonal
anti-JMJD6 antibodies, and a mouse monoclonal antibody against
JMJD6 (data not shown). This banding pattern is in agreement
with previous reports (Hahn et al., 2010; Han et al., 2012; Tibrewal
Fig. 1. The DM-RHA antibody recognizes the non-methylated C-terminus of RHA. (A) Uninfected (mock) and virus-infected (A24 Cruzeiro, O1 Campos, and C3 Resende) LFBK
cells were examined by IFM at 1, 3, and 5 hpi probing with mouse monoclonal anti-DM-RHA (red). The nuclei were stained with DAPI (blue). Slides were examined with
a 100 oil immersion objective. Scale bars represent 10 μm. (B) Diagram of proposed mode of detection of anti-DM-RHA. (C) Western blot of BHK-21, LFBK, and CHO 677 cell
lysates probed with anti-DM-RHA. (D) Western blot of insoluble pellet (P) and soluble supernatant (S) material of bacterially expressed GST-tagged N-terminal and
C-terminal fragments of RHA, probed with either anti-GST or anti-DM-RHA.
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et al., 2007). As expected, a band at approximately 70 kDa matches
the size of what was previously determined to be glycosylated
monomeric JMJD6 (labeled as G) after cell lysates were treated
with glycosylase (Fadok et al., 2000; Hahn et al., 2010; Tibrewal
et al., 2007). Of note, the higher molecular weight JMJD6-related
bands have been described to correspond to homo-multimers of
JMJD6 (M1, M2, M3, and M4), which are interestingly resistant to
denaturing and reducing conditions. The existence of as many as
Fig. 2. RHA redistribution is sensitive to NOG. (A) Evaluation of cytotoxicity of NOG at a range of concentrations (0–7 mM) on mammalian cells by XTT assay. (B) Mock
uninfected and FMDV-infected (5 hpi) cells incubated with and without 2 mM NOG were examined by IFM probing with rabbit polyclonal anti-RHA (green). Nuclei were
stained with DAPI (blue). Scale bars represent 20 μm. (C) Western blot of NOG treated, FMDV-infected cell lysates probed with anti-FMDV 3Dpol followed by anti-tubulin.
Replicates (n¼3) of the representative Western blot were subject to densitometry scanning, and the mean arbitrary units (AU) representing the relative amount of FMDV
3Dpol present were indicated. (D) The resulting virus titers were plotted as log10 PFU/mL.
Fig. 3. Comparison of JMJD6 and RHA expression in selected mammalian cell lines.(A and B) Whole cell lysates (WCL) and nuclear (N) and cytoplasmic (C) fractions from
uninfected LFBK and CHO 677 cell lines were examined by Western blot probing with anti-RHA (A) and anti-JMJD6 (B). Bands corresponding to glycosylated monomeric
JMJD6 and increasing homo-multimers of JMJD6 are indicated as G, M1, M2, M3, and M4, respectively. WCL of BHK-21 cells was also included.
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three different JMJD6 isoforms reportedly conserved from mice to
humans have been described (Hahn et al., 2008). Interestingly,
sub-cellular fractionation patterns differ slightly among the cell
lines examined. For instance, JMJD6 was exclusively cytoplasmic in
hamster CHO 677 cells, but exhibited a split nuclear/cytoplasmic
distribution in LFBK cells, which are of bovine origin (Fig. 3B). Also,
the single band observed in the nuclear fraction of LFBK cells was
not seen in cytoplasmic fractions of LFBK and CHO 677 cells, nor
the WCL of BHK-21 cells. As a control, the blots were re-probed for
RHA expression, showing that RHA was predominantly if not
exclusively found in the nuclear fraction (Fig. 3A).
JMJD6 subcellular localization is altered during FMDV infection.
To test whether the expression or distribution of JMJD6 is
altered during FMDV infection of host cells, we examined mock-
infected and FMDV-infected LFBK cells by IFM, probing with anti-
JMJD6 and anti-FMDV-VP1 antibodies. For comparison, parallel
infections with bovine enterovirus (BEV-1), belonging to the
family Picornaviridae genus Enterovirus, were also examined. As
can be seen in Fig. 4A, JMJD6 was found predominantly in the
cytoplasm of mock-infected and at 1 hpi in FMDV-infected cells
with some faint nuclear ﬂuorescence. By 3 hpi, the detection of
JMJD6 became noticeable in the nucleus of infected cells, and by
5 hpi, JMJD6 was almost exclusively nuclear (Fig. 4A). When
repeated using the related BEV-1, the cytoplasmic to nuclear
redistribution visualized during FMDV infection of LFBK cells was
not observed (Fig. 4B). Furthermore, to conﬁrm that nuclear
accumulation of JMJD6 was speciﬁc to FMDV-infected cells, LFBK
cells infected with FMDV at 5 hpi were examined by IFM with
antibodies against FMDV VP1 protein and JMJD6 (Fig. 4C). Cells
that exhibited nuclear accumulation of JMJD6 also stained positive
for FMDV capsid protein VP1. The nuclear accumulation of JMJD6
with progression of FMDV infection was quantiﬁed evaluating the
change in the ratio of nuclear/cytoplasmic (r N/C) ﬂuorescence
relative to BEV-1 infected cells using arbitrary units (Fig. 4D and E).
The mean ﬂuorescence intensity associated with JMJD6 revealed that
the ﬂuorescent intensity within the nuclei of FMDV-infected cells
increased more than 2 times by 5 hpi (Fig. 4D). This contrasts with
the overtime reduction in ﬂuorescent intensity detected in the nuclei
of BEV-1-infected cells (Fig. 4E). Thus, the results demonstrated that
the phenomenon of JMJD6 redistribution to the nuclei is speciﬁc to
FMDV, but was not exhibited by the related enterovirus, BEV-1.
Evidence of JMJD6 interaction with RHA by co-immunoprecipitation.
As the methyltransferase PRMT1 was shown to bind RHA in the
C-terminal nuclear transport domain and affect the asymmetric
dimethylation of arginine residues therein (Smith et al., 2004), we
sought to directly demonstrate the interaction between RHA and
JMJD6 via co-immunoprecipitation experiments (Fig. 5). To this
end, uninfected and FMDV-infected LFBK cells were examined at
Fig. 4. FMDV infection triggers the re-localization of JMJD6. Cells were mock-treated or infected with FMDV (A) or BEV-1 (B) and examined at 1, 3, and 5 hpi by IFM probing
with anti-JMJD6 (green). Nuclei were stained with DAPI (blue). Slides were examined with a 100 oil immersion objective. (C) FMDV-infected cells at 5 hpi were examined
by IFM as above (A, B), except they were also probed with anti-VP1 (red) and the images of from each ﬂuorescent ﬁlter were merged. Scale bars represent 20 μm. Cells were
mock-treated or infected with FMDV (D) or BEV-1 (E) and examined at 5 hpi by IFM probing with anti-JMJD6 (green). Slides were examined with a 100 oil immersion
objective. Scanned images were imported into ImageJ and the relative ﬂuorescence intensity (represented in arbitrary units) within the nuclei and cytoplasm of no less than
3 cells per panel was quantiﬁed. The average ratio of nuclear to cytoplasm ﬂuorescence (r N/C) was calculated. A representative cell from each panel was shown (inset). Scale
bars represent 20 μm.
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different time points (lysates prepared at 1, 3, and 5 hpi) and
separately immunoprecipitated with an antibody targeted to either
the C-terminus of JMJD6 (Fig. 5A) or with a rabbit polyclonal anti-
RHA (Fig. 5B). Eluates from each immunoprecipitation (IP) reaction
were examined by Western blot (IB) probing with anti-C-terminal
JMJD6 (Fig. 5A). The anti-JMJD6 antibody reaction shown in the
lower panel of Fig. 5A detected a single faint band with a molecular
weight of approximately 70 kDa, (consistent with the molecular
weight of glycosylated monomeric JMJD6) that signiﬁcantly
increased by 3 hpi to subsequently weaken by 5 hpi. The blot in
Fig. 5B represents the reciprocal anti-JMJD6 IP reaction probing
with anti-RHA. The blot shown in the lower panel of Fig. 5B
revealed a single band migrating at about 140–150 kDa, consistent
with the molecular weight of RHA. As with the IP reaction described
for Fig. 5A, the RHA-speciﬁc band was faint at 1 and 5 hpi, and
exhibited increased intensity at 3 hpi. At present, we are unclear of
the nature of the basal interaction observed between JMJD6 and
RHA seen in mock-infected cells, but it may relate to the functions
these proteins exert in the host cell (see the Introduction). Note-
worthy, similar experiments measured at different times and
repeated three times were reproducible and in accordance with
each other. Together, these ﬁndings provide evidence for the
physical interaction between JMJD6 and RHA via reciprocal co-
immunoprecipitation reactions, a phenomenon that appears to
peak at a time (3 hpi) coincident with the increased accumulation
of JMJD6 in the nucleus and increased efﬂux of demethylated RHA
to the cytoplasm of FMDV-infected cells.
Assessment of JMJD6-induced demethylation of RHA and its truncated
splice variants.
To further examine the role of JMJD6 in RHA demethylation,
studies were performed utilizing recombinant RHA and JMJD6
proteins and using an in vitro arginine demethylation assay. The
method was adapted from Tsukada and Zhang (2006) and originally
designed for testing lysine demethylation of histone proteins. In our
modiﬁed assay, the detection of demethylated products was facili-
tated by Western blot analysis using the speciﬁc anti-DM-RHA
antibody (Fig. 6, see also Fig. 1). Fig. 6A displays a representation of
the basic reaction component of this assay. Samples corresponding
to mammalian-expressed and afﬁnity-puriﬁed FLAG-tagged RHA
(FLAG-RHA) were mixed with increasing amounts of puriﬁed
recombinant JMJD6 (from 2 different manufacturers; see Materials
and methods) in a reaction containing appropriate buffer solution
and key co-factors of the demethylation reaction carried out by
members of the JmjC superfamily of demethylases: 2-OG and iron
(Fe-II) as shown in Fig. 6A. The reactions were incubated at 37 1C for
5 h as described in Materials and methods section, and subse-
quently evaluated by Western blot probing with anti-DM-RHA. The
results in Fig. 6B revealed that reactions carried out with increasing
amounts of JMJD6 produced greater amounts of demethylated RHA,
with the expected molecular weights of FLAG-RHA and residual
endogenous RHA (labeled FLAG-RHA and RHA respectively in
Fig. 6B). Also shown in Fig. 6B, are two predominant bands of
approximately 60 and 28 kDa coincident with the molecular
weights expected for two known RHA splice variants: an unnamed
60 kDa isoform (Accession # BAG53328.1) and leukophysin (LKP),
respectively (Supplementary Fig. 2) (Abdelhaleem et al., 1996; Ota
et al., 2004). Loading equivalency in each reaction mixture was
conﬁrmed by re-probing the blot with anti-tubulin and polyclonal
anti-RHA (which detect total RHA). Fig. 6C shows the results of
similar parallel reactions examined using increasing amounts of
JMJD6 by Western blot probing with anti DM-RHA antibody and in
the presence or absence of the NOG inhibitor. As shown in the left
blot of Fig. 6C, the NOG treatment was able to prevent the detection
of DM-RHA even at a slightly higher (1.25 mg) concentration of
JMJD6. The second blot to the right and the one below in Fig. 6C
represent loading controls examined either by probing with an
antibody that detects total RHA or by Coomassie blue staining.
Together, the results provide evidence that puriﬁed JMJD6 is
capable of inducing the demethylation of RHA and two RHA-
derived isoforms in a dose-dependent manner (Fig. 6B). These
catalyzed products have a C-terminal sequence domain in common,
which contains RG/RGG repeats that are recognized by the anti-
DM-RHA antibody (Supplementary Fig. 2).
Discussion
Utilization of RNA binding proteins by picornaviruses is impor-
tant during viral infection. The availability of certain nuclear RNA
binding proteins in the cytoplasm, where viral RNA replication
takes place is particularly critical. In this study, we provide new
insight into the involvement of the arginine demethylase JMJD6 in
the physical alteration and redistribution of RHA to the cytoplasm
during FMDV infection. As depicted in Fig. 7, we hypothesized that,
Fig. 5. RHA co-precipitates with JMJD6 during FMDV infection. (A) Cell lysates from mock and FMDV-infected cells at 1, 3, and 5 hpi were immunoprecipitated (IP) with
polyclonal anti-RHA and the eluates examined by Western blot probing (IB) with polyclonal anti-C-terminal JMJD6 (lower panel). (B) Conversely, the individual lysates were
immunoprecipitated (IP) with polyclonal anti-C-terminal JMJD6 and the eluates examined by Western blot probing (IB) with polyclonal anti-RHA. One representative result
of at last three experiments performed. The input lysate material for each set of immunoprecipitation reactions was examined by Western blot probing with the indicated
antibodies (top panels). Similar results found for reciprocal coIP was obtained from three independent studies.
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similar to the binding of the methyltransferase PRMT1 to the
C-terminus of RHA (Smith et al., 2004), JMJD6 could physically
interact with and induce a change in methylated arginine residues
within the RHA C-terminus resulting in RHA redistribution to the
cytoplasm. Indeed, the direct physical interaction between RHA
and JMJD6 was conﬁrmed by co-immunoprecipitation (Fig. 5) and
the NOG inhibitor of the JmjC family of protein demethylases was
shown to effectively prevent the re-localization of RHA to the
cytoplasm during FMDV infection, with consequent reduction of
viral protein expression and virus titers (Fig. 2). JMJD6 expression
was conﬁrmed in different mammalian cell lines frequently used
to grow and characterize FMDV phenotypes (Fig. 3). Following
infection with FMDV representing three different serotypes, the
progressive accumulation of JMJD6 is detected in the cell nucleus,
and appears to be a FMDV-speciﬁc phenomena, since a related
picornavirus, BEV-1, failed to display this pattern.
The most important conclusion derived from our study is that
FMDV infection triggers an enhanced interaction between JMJD6
with RHA in the nucleus, that induces RHA demethylation which is
observed at 3 hpi when RHA cytoplasmic re-localization becomes
readily detectable. As we previously described (Lawrence and
Rieder, 2009), cytoplasmic DM-RHA appears to form ribonucleo-
complexes with the S-fragment at the 50 terminus of the 50 non-
translated region (NTR) of the viral genome, and to interact with
viral proteins 2C and 3A as well as host protein PABP and these
could serve a role in FMD virus replication (Fig. 7). It is also
noteworthy that, although protein demethylases are a relatively
recent discovery and reports of their participation in viral infec-
tions are likely to expand, this is the ﬁrst time that JMJD6 has been
shown to be responsible for the demethylation of RHA as well as 2
RHA-derived truncated isoforms: BAG53328.1 and LKP (Fig. 6).
The signiﬁcance of these ﬁndings is four-fold. First, these
ﬁndings represent a novel instance of an arginine demethylase
involved in a virus life cycle. The involvement of closely related
lysine demethylase in the life cycle of herpes simplex virus has
been demonstrated, where the viral ICP0 protein was shown to
interact with the REST/CoREST repressor complex containing the
lysine demethylase, LSD1 (Gu and Roizman, 2009; Liang et al.,
2009). Similarly, LSD1 has also been shown to interact with the
latency promoter of the Epstein–Barr virus (Chau et al., 2008) and
more recently in the latency period of HIV in infected T-cells
(Sakane et al., 2011). Whether any additional cellular or viral
Fig. 6. JMJD6 demethylates RHA in vitro. (A) Depiction of the arginine demethylation chemical reaction. (B) Western blot of samples from in vitro demethylase assay probed
ﬁrst with anti-DM-RHA (top panel), stripped and re-probed with anti-RHA (middle panel), and ﬁnally stripped and re-probed with anti-tubulin (bottom panel). (C) Western
blot of an in vitro demethylase assay (right panel) as described in B where an alternative source of JMJD6 was substituted and one reaction set was co-incubated with NOG
(left panel). Protein loading in each lane was evaluated by stripping and re-probing the blot with polyclonal rabbit anti-RHA (bottom panel), and Coomassie blue staining of
the reaction sets loaded on a 12% SDS-PAGE gel (right panel).
Fig. 7. Proposed model of JMJD6 and RHA activity during FMDV infection. Depicted
is the proposed mechanism by which FMDV triggers the nuclear efﬂux of RHA
through the activity of JMJD6: FMDV infection triggers the re-localization of JMJD6
from the cytoplasm to the nucleus, where it catalyzes the demethylation of RHA.
De-methylated RHA exits the nucleus to the cytoplasm, where it interacts with the
50 non-translated region of the positive-sense single-stranded RNA (ssRNAþ)
FMDV genome and viral proteins 2C and 3A as well as host protein PABP,
potentially contributing to the process of RNA replication.
P. Lawrence et al. / Virology 452-453 (2014) 1–11 7
protein(s) are involved in JMJD6 interactions remains an open ﬁeld
for investigation. Although hypothetical, it seems likely that the
FMDV-induced nuclear concentration of JMJD6 would render other
nuclear proteins asymmetrically di-methylated at their arginine
residues, just like RHA.
Secondly, the emerging role of JMJD6 in the FMDV life cycle
adds to the complexity of functions mediated by this protein.
JMJD6 was ﬁrst described as a phosphatidyl serine receptor (PSR)
localized to the cell surface, and responsible for recognition of
apoptotic cells (Cao et al., 2004; Fadok et al., 2000; Hoffmann
et al., 2001). However, later studies pinpointed JMJD6 in the
nucleus interacting with histones and a variety of splicing and
transcription factors (Chang et al., 2007; Cikala et al., 2004; Cui
et al., 2004; Hahn et al., 2010; Tibrewal et al., 2007; Webby et al.,
2009). Therefore, our ﬁndings reinforce the latter contention that
JMJD6 is a key mediator of cellular functions in the nucleus. The
nuclear accumulation of JMJD6 in FMDV infected cells resembled
the movement pattern of this protein in the human myeloid THP-1
cell line following treatment with phorbol 12-myristate 13-acetate
(Zakharova et al., 2009).
Thirdly, the majority of investigations into protein demethyla-
tion have focused on histone proteins and the consequences to the
so-called “histone code”. Only a few reports are describing the
lysine demethylation of a non-histone protein (Cho et al., 2011;
Huang et al., 2007; Nicholson and Chen, 2009). Interestingly JMJD6
has been reported to interact with the RNA splicing factor U2AF65
(Webby et al., 2009). It seems likely that increased examination of
reversible protein methylation will elucidate additional non-
histone substrates of demethylases, just like the JMJD6-RHA
interaction documented in our current study.
Lastly, the modiﬁed in vitro demethylation assay combined with
an antibody that speciﬁcally detects the modiﬁed residues (anti DM-
RHA antibody) described herein represents a simpler method of
characterizing the demethylase activity of JMJD6 and other potential
JmjC domain containing arginine demethylases. Our method detect
demethylated recombinant FLAG-tagged RHA expressed in mamma-
lian cells as well as endogenous RHA and its truncated splice
variants: BAG53328.1 and LKP. Interestingly, BAG53328.1 and parti-
cularly LKP appeared especially reactive with JMJD6, which we
hypothesize may be due to reduced steric interference deduced from
homology models showing greater accessibility of RG/RGG repeats
on the surfaces of BAG53328.1 and LKP (Supplementary Fig. 3).
Currently, the complete molecular structure of RHA has yet to be
determined by either X-ray crystallography or NMR spectroscopy,
rather only the crystal structure of the N-terminal RNA-binding
domains has been solved. While we were unable to generate a
homology model of the full RHA sequence with the computer
algorithms currently available, we speculate that the large multi-
domain protein may present certain steric hindrances to JMJD6
binding. Perhaps, once in the nucleus, cytoplasmic substrates like
LKP would not be available to compete with RHA for enzymatic
demethylation by JMJD6. Until now, the existing in vitro assays have
been tailored for the evaluation of lysine demethylase activity on
histones, and have yet to be validated for non-histone proteins or
arginine demethylases (Kokura and Fang, 2009; Tsukada and Zhang,
2006). Most reports of JMJD6 demethylase activity have been
illustrated through specialized methodologies involving mass spec-
trometry analysis. The adaptation we made of the in vitro assay
produced by Cayman Chemical represents a useful system speciﬁ-
cally designed for evaluation of the enzymatic activity of JmjC
arginine demethylases.
The identiﬁcation and characterization of protein demethy-
lases remains a relatively recent advancement in our under-
standing of the dynamics of post-translational modiﬁcations in
mammalian cells, especially within the context of the “histone
code”(Gardner et al., 2011). Very limited evidence exists for their
involvement in the demethylation of non-histone proteins (Cho
et al., 2011; Gu and Roizman, 2009; Liang et al., 2009; Nicholson
and Chen, 2009), which adds to the novelty of our ﬁndings
with respect to JMJD6-mediated RHA demethylation induced
during FMDV infection. These ﬁndings further illustrate a
distinct mechanism employed by a RNA virus of limited coding
capacity to modify the intracellular environment to suit its
replication cycle.
Materials and methods
Materials
N-oxalylglycine (NOG), leptomycin B (LMB), rabbit polyclonal anti-
FLAG antibody and mouse monoclonal anti-FLAG (M2) coupled
agarose beads were purchased from Sigma-Aldrich (Saint Louis, MO).
Fugene-HD DNA transfection reagent was purchased from Promega
(Madison, WI). Nuclear and cytoplasmic extraction kit was purchased
from Thermo Scientiﬁc (Rockford, IL). Jumonji demethylase assay
buffer was purchased from Cayman Chemical Company (Ann Arbor,
MI). Puriﬁed recombinant JMJD6 transcript variant 1 was purchased
from two different manufacturers: Origene (Rockville, MD) and
Cayman Chemical Company (Ann Arbor, MI).
Antibodies
Polyclonal rabbit anti-JMJD6 antibodies, mouse monoclonal anti-
DM-RHA, and HRP-conjugated mouse monoclonal anti-GST anti-
bodies were purchased from Abcam (Cambridge, MA). Polyclonal
rabbit anti-RHA, goat-anti-rabbit-HRP, and goat-anti-mouse-HRP
were purchased from Bethyl Laboratories (Montgomery, TX). Goat-
anti-rabbit antibodies conjugated to AlexaFluor-488 (AF488) and
goat-anti-mouse antibodies conjugated to AlexaFluor-568 (AF568)
were purchased from Molecular Probes (Carlsbad, CA).
Cell lines
Baby hamster kidney strain 21, clone 13 cell line (BHK-21) was
maintained in Eagle0s basal medium (BME) (Life Technologies,
Gaithersburg, MD) supplemented with 10% calf serum (CS)
(Hyclone, South Logan, UT), 10% tryptose phosphate broth, 1%
L-glutamine, and antibiotic/antimycotic (A/A). The LFBK and 293T/
17 cell lines were cultured in Dulbecco0s minimal essential media
(DMEM) supplemented with 10% fetal bovine serum (FBS) and 1%
A/A (Swaney, 1988). The CHO 677 cell line was cultured in Ham0s
media supplemented with 10% FBS and 1% A/A. Cells were grown
at 37 1C in a humidiﬁed 5% CO2 atmosphere.
Viruses and plasmids
Wild-type (WT) FMDV type A24 Cruzeiro/Brazil 1955 (A24
Cruzeiro, Accession #AY593768) was derived from the infectious cDNA
clone pA24Cru (Rieder et al., 1993, 2005). Isolates of FMDV O1 Campos
and C3 Resende viruses and bovine enterovirus 1 (BEV-1, Gb D00214)
were obtained from Drs. Marvin Grubman or Peter Mason, Agricul-
tural Research Service, Plum Island. Expression plasmids for the
N-terminus (RHA1) and the C-terminus (RHA4) of RHA were kindly
provided by Dr. Toshi Nakajima (Aratani et al., 2001).
Plasmid transformation
BL21-DE3 chemically competent bacterial cells (Novagen) were
transformed with the indicated plasmids by the heat shock method.
Brieﬂy, cells were incubated with the plasmid on ice for 20 min
followed by a 30 s heat shock at 42 1C, and then were returned to ice
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for an additional 2 min. The cells were mixed with LB media,
incubated at 37 1C for 1 h, and spread plate onto LB agar plates with
corresponding antibiotic. Selected colonies were grown up in LB
media until an OD500 of 0.8, at which time protein production was
induced by the addition of 1 mM IPTG. Cells were then incubated at
37 1C for an additional 3 h until an OD500 of 1.5. Cells were pelleted,
lysed using BugBuster reagent (following Novagen protocols), and
separated into soluble and insoluble fractions.
Plasmid transfection
Mammalian cells were transfected with plasmid DNA using the
Fugene-HD transfection reagent (Promega) following the man-
ufacturer0s protocol. Brieﬂy, cells were grown to approximately
30–40% conﬂuence. The cell culture medium was replaced with
serum-free media containing the desired plasmid and Fugene-HD
(Promega). Cells were incubated with the mixture for 48 h at
37 1C. The cells were harvested and examined by Western blot to
conﬁrm expression.
Immunoﬂuorescent microscopy
Cells were grown on glass coverslips in 12-well plates until
approximately 40% conﬂuence. Mock-treated cells were ﬁxed with
4% paraformaldehyde (PF) in PBS for 10 min at room temperature (RT)
prior to the introduction of virus into adjacent wells. The remaining
wells were infected withWT FMDV A24 Cruzeiro or the speciﬁed virus
at a MOI of 10 plaque forming units (PFUs) per cell and incubated at
37 1C for 1, 3 or 5 hpi. Excess virus was removed by acid-washing the
cells brieﬂy followed by several rinses with virus growth media (VGM:
BME with 1% L-Glutamine and 1% antibiotic/antimycotic). Cells repre-
senting different time points were then ﬁxed with 4% PF. Remaining
cells were incubated with fresh VGM for 3 or 5 hpi at 37 1C, and later
ﬁxed with 4% PF. Cells were washed in PBS, permeabilized with 0.1%
Triton-X100 in PBS on ice, and blocked with blocking buffer (3% BSA,
0.3 M glycine, 10% normal goat serum) at RT. Then, the cells were
probed with primary antibodies overnight at 4 1C, and the following
day incubated with goat-anti-rabbit-AF488 and/or goat-anti-mouse-
AF568 (Molecular Probes) for 1 h. The coverslips were washed with
PBS after each antibody treatment. Finally, the coverslips were air-
dried and mounted onto glass slides with ProLong antifade medium
supplemented with DAPI stain (Molecular Probes). Cells were exam-
ined and images captured using a 100 oil immersion objective on an
Olympus ﬂuorescent microscope (Center Valley, PA). Images were
reﬁned and ﬁgures generated using Adobe Photoshop software (Adobe
Systems Incorporated, San Jose, CA).
Western blot
SDS-PAGE (sodium dodecyl sulfate-polyacrylamide gel electro-
phoresis) was carried out using a 12% Nu-PAGEs pre-cast gel
system (Invitrogen). Separated proteins were electro-blotted onto
a nitrocellulose membrane (Sigma), and blocked with 5% milk in
PBS-T. Proteins were detected with primary antibodies at indicated
dilutions followed by goat-anti-rabbit or goat-anti-mouse antibo-
dies conjugated with HRP (Sigma). Cellular tubulin, employed as
an internal loading control protein, was detected with anti-
tubulin-α (Sigma). HRP conjugate antibodies were reacted with
WestDura SuperSignal chemiluminescent reagent (Pierce) accord-
ing to the manufacturer0s instructions and visualized on X-ray ﬁlm
(X-Omat; Kodak, N.Y., USA).
Co-immunoprecipitation
Following the manufacturer0s protocol, antibodies directed against
RHA or JMJD6 were separately bound to the Protein A/G agarose
beads provided in the Pierce Crosslink Co-immunoprecipitation Kit
(Pierce). LFBK cells uninfected or infected with FMDV for 1, 3, or 5 h
were lysed with 1X RIPA buffer (1% Nonidet-P40, 0.5% sodium
deoxycholate, 0.1% SDS, and 1X PBS) supplemented with protease
inhibitors and Benzonase™ (Novagen, Gibbstown, NJ). Subsequently,
uninfected or virus-infected cell lysates were individually mixed with
the different sets of antibody-coupled beads, washed, and eluted.
Eluates were mixed with Laemmli sample buffer (Laemmli, 1970),
boiled, and analyzed by Western blot probing with antibodies against
RHA (Bethyl Laboratories) or JMJD6 (Abcam).
Demethylase assay
FLAG-tagged RHA was expressed in 293T/17 cells as previously
described (Lawrence and Rieder, 2009), and was subsequently
puriﬁed using agarose coupled to mouse monoclonal M2 anti-
FLAG (Sigma). Recombinant puriﬁed JMJD6 (Z80% purity accord-
ing to manufacturers, Origene and Cayman Chemical Company)
and afﬁnity-puriﬁed FLAG-RHA were mixed in equal proportions
with demethylase assay buffer containing 20 mM Tris–HCl, pH
7.5 and Jumonji co-factors: 2-OG and Fe(II) (Cayman Chemical
Company). The reactions were incubated at 37 1C for 5 h, and the
resulting samples were evaluated for the presence of demethy-
lated RHA by Western blot probing with anti-DM-RHA (Abcam)
followed by anti-tubulin (Abcam), and then anti-RHA (Bethyl
Laboratories). Additional reactions were performed to conﬁrm
the speciﬁcity of the demethylase activity, where reaction condi-
tions were identical, but with co-incubation with 2 mM NOG.
Structural analysis
Amino acid sequences of BAG53328.1 and Leukophysin (LKP)
were used to construct homology models using the SAMT08
algorithm (Karplus et al., 1998, 1997). Hypothetical structures
were examined using DeepView (Guex and Peitsch, 1997; Kaplan
and Littlejohn, 2001), and a consensus structure for each sequence
was selected.
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